Learn More
AIM Cardiovascular disease is a leading cause of morbidity and mortality in end-stage renal disease (ESRD) patients on maintenance hemodialysis (HD). Neither traditional nor emerging risk factors for cardiovascular disease can explain completely this excess of morbidity and mortality and the role and timing of primary prevention strategies in this(More)
Stimulation of the cholinergic system tightly coupled with periods of visual stimulation boosts the processing of specific visual stimuli via muscarinic and nicotinic receptors in terms of intensity, priority and long-term effect. However, it is not known whether more diffuse pharmacological stimulation with donepezil, a cholinesterase inhibitor, is an(More)
A large body of literature supports cognitive enhancement as an effect of cholinergic potentiation. However, it remains elusive whether pharmacological manipulations of cholinergic neurotransmission enhance complex visual processing in healthy individuals. To test this hypothesis, we randomly administered either the cholinergic transmission enhancer(More)
The muscarinic and nicotinic transmissions in the primary visual cortex (V1) are involved in the enhancement of specific visual stimuli as well as long-term modifications of the neuronal processing, in regards to perceptual learning. We investigated the involvement of the different cholinergic receptors subtypes underlying this long-term functional(More)
Donepezil enhances the cholinergic synaptic transmission in the brain by inhibiting the enzyme that metabolizes acetylcholine in the synaptic cleft, thereby prolonging the action of this neurotransmitter. It has been demonstrated that chronic administration of donepezil increases perceptual learning. Our study examines the effect of acute administration of(More)
  • 1